Headquartered in Westbury, New York, our facilities total 105,000 sq. ft., with 40,000 sq. ft. devoted to corporate headquarters and 65,000 sq. ft. as our northeast distribution center. The northeast distribution center is highly productive, efficient, and safe. It has become the model for our entire distribution network with high ceilings, narrow aisles, and wire-guided material handling.

In 2022, PLD and Avéma added gummy manufacturing capabilities by purchasing a CFR 2111 and CFR 111- compliant facility in Copiague, NY that manufactures gummies and gums

In 2022, Avéma and PLD added a new 135,000 sq. ft. manufacturing, packaging and R&D facility in Miami, Florida, which complies with the most stringent FDA and cGMP requirements. The building will house our newly designed R&D lab, which will triple the size and capabilities of our previous R&D Center. We produce a full selection of oral solid dosage forms for the Rx, OTC and nutritional supplement industries, as well as offer formulation, process and analytical development in support of a company’s new or existing products.

Avéma offers formulation, process and analytical development support of a company’s new or existing products. We are strong partners in the development process, providing sound scientific and technical expertise, excellent project management skills and exceptional communications – all of which are critical for bringing products to market quickly.

Avéma’s two facilities in South Carolina encompass 200,000 sq. ft. for the manufacturing of liquid topicals and first aid products. An additional 300,000 sq. ft. is being configured to support new and innovative manufacturing techniques.

Avéma’s facility in California includes 250,000 sq. ft. for the manufacturing of liquid OTC and RX oral products.